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Edited by Veli-Pekka LehtoAbstract Shigella, the causative agent of bacillary dysentery,
invades epithelial cells. Upon bacterial–cell contact, the type
III bacterial eﬀector IpaA binds to the cytoskeletal protein vin-
culin to promote actin reorganization required for eﬃcient bac-
terial uptake. We show that the last 74 C-terminal residues of
IpaA (A559) bind to human vinculin (HV) and promotes its asso-
ciation with actin ﬁlaments. Polymerisation experiments demon-
strated that A559 was suﬃcient to induce HV-dependent partial
capping of the barbed ends of actin ﬁlaments. These results sug-
gest that IpaA regulates actin polymerisation/depolymerisation
at sites of Shigella invasion by modulating the barbed end cap-
ping activity of vinculin.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Shigella, a gram-negative bacillus known as the major etio-
logical agent of dysentery in developing countries, mediates
its entry into epithelial cells by a trigger-like process involving
a type III secretion apparatus and injection of several bacterial
type III eﬀectors [1,2]. Bacterial entry into host cells requires
the dynamic polymerisation and depolymerisation of actin,
which serves to mould the contact site to allow eﬃcient entry
of the pathogen [2]. The type III eﬀector IpaA binds to vincu-
lin, and the IpaA–vinculin complex induces actin depolymer-
isation, which is required for eﬀective bacterial entry [3,4].
Vinculin, a highly conserved cytoskeletal component of focal
adhesions, plays critical roles in various processes such as cel-q While this paper was submitted, a work by Demali et al. reported
that the ﬁrst 500 amino-terminal residues of IpaA could induce
vinculin-independent actin depolymerisation following cell transfec-
tion [24].
*Corresponding author. Fax: +33 1 45 68 89 53.
E-mail address: gtranvan@pasteur.fr (G. Tran Van Nhieu).
1Present address: Unite´ de Ge´ne´tique Microbienne et Environnement,
INRA La Minie`re, 78285 Guyancourt, France.
2Present address: Danone Vitapole, Nutrivaleur, 91767 Palaiseau
Cedex, France.
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.01.057lular adhesion and motility, as well as in embryonic develop-
ment and tumorigenesis [5–7]. Vinculin is comprised of ﬁve a-
helical bundle domains that form a large globular head, and
a ﬁve-helical bundle tail (Vt) domain, which is connected to
the head via a proline-rich hinge region [8]. The isolated head
domain of vinculin binds to talin and a-actinin, while the iso-
lated tail domain binds F-actin [9,10]. However, in its native
state an intramolecular interaction between the N-terminal se-
ven-helical bundle domain (Vh1) of vinculin with its Vt tail do-
main clamps vinculin in a closed conformation, and masks its
binding sites to some of its ligands such as F-actin and paxillin
[11]. The binding of the vinculin-binding sites (VBSs) present in
the central rod domains of talin or a-actinin with the Vh1
domain induces conformational changes that displace the
head–tail interaction and are alone suﬃcient to trigger vinculin
binding to F-actin, a hallmark of vinculin activation [11–13].
Here we report that the 74-residues C-terminal domain of IpaA
activates vinculin binding to actin and mediates vinculin-
dependent capping of the barbed end of actin ﬁlaments.2. Materials and methods
2.1. Antibodies
The rabbit anti-IpaA antiserum was previously described [3]. The
mouse anti-vinculin monoclonal antibody Vin11.5, and the rabbit
anti-actin were from Sigma Corp (St. Louis, MO). The anti-rabbit
IgG HRP antibody was from Amersham Corp.
2.2. Bacterial strains and plasmid constructs
S. ﬂexneri strains are derivatives of the wild-type strain M90T [14].
Strain SF635, in which the ipaA, B, C and D genes have been deleted
(Dipa) was used for puriﬁcation of IpaA [15]. Bacteria were grown in
tryptic casein soy broth (TCBS) at 37 C. To obtain the IpaA deriva-
tives AD1, AD2 and AD3, internal deletions of the ipaA gene in the
plasmid pBad18::ipaA [16] were performed between residues 69
(Bsu36I) to 139 (PshA1) (AD1), 139 (PshA1) to 420 (StuI) (AD2) and
419 (StuI), as well as a C-terminal deletion from residues 552–633
(SnaBI) (AD3). The Dipa strain was transformed with plasmid pBa-
d18::AD1 (Dipa-AD1), pBad18::AD2 (Dipa-AD2) or pBad18::AD3
(Dipa-AD3) or with pBad18::ipaA (Dipa-IpaA). A559 is a fusion pro-
tein containing GST fused to the C-terminal residues 513–633, or
560–633 of IpaA, respectively, expressed from a derivative of pGEX-
4T2 in E. coli.
2.3. Puriﬁcation of proteins and overlay assays
IpaA was puriﬁed from cultures of a Dipa/pBad: IpaA strain as
previously described [4]. GST-N and A559 fusions were puriﬁed using
glutathione beads, according to the manufacturer’s instructions.blished by Elsevier B.V. All rights reserved.
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Vinculin overlay assays were performed as previously described [3,17].
2.4. Actin sedimentation assays
Recombinant vinculin (1.8 lM) and IpaA or the A559 derivative
(200, 400 or 800 nM), were added to 3 lM G-actin (cytoskeleton) dur-
ing the polymerisation reaction in F-buﬀer (2 mM Tris pH 7.5, 0.2 mM
CaCl2, 0.2 mM ATP, 100 mM KCl and 2 mM MgCl2) for 1 h at room
temperature (RT). Proteins were centrifuged at 70000 · g for 30 min in
a TL-100 ultracentrifuge (Beckman). Pellet and supernatant fractions
were analysed by SDS–PAGE and Coomassie staining.
2.5. Polymerisation assays using pyrenyl-actin ﬂuorescence
Actin was puriﬁed from rabbit muscle and labelled on cysteine 374
by pyrenyl iodoacetamide [18,19]. For measurements of the initial rate
of barbed end growth, samples of 2 lM actin (10% pyrenyl-labelled)
containing 0.2 nM spectrin-actin seeds were supplemented with vincu-
lin (0–20 lM) and/or A559 (0–15 lM). Polymerisation was started by
addition of 100 mM KCl, 0.2 mM EGTA and 1 mM MgCl2 to the
solution in G-buﬀer. For measurements of dilution-induced depoly-
merisation at barbed ends, 25 lM actin (75% pyrenyl labelled) was
polymerised by addition of 1 mM MgCl2, 0.2 mM EGTA and
100 mM KCl for 20 min at RT. F-actin was then diluted to 67 nM
in F buﬀer and supplemented with vinculin (0–2 lM) and/or A559
(0–2 lM). The initial rate of decrease in ﬂuorescence of pyrenyl-F-actin
was measured. Changes in ﬂuorescence were recorded using a Safas ﬂx
spectroﬂuorometer. The excitation and emission monochromators
wavelengths were set at 366 nm and 407 nm, respectively.Fig. 1. The 74 C-terminal residues of IpaA mediate binding to
vinculin. (A) The structure of IpaA derivatives containing either
internal deletions between residues 69–139 (AD1), 139–420 (AD2),
419–633 (AD3), or 559–633 (ADCT), or GST fused to the C-terminal
residues 514–633 (A513) or 560–633 (A559) of IpaA is shown. (B)
Supernatants from Dipa-IpaA, AD1, AD2, AD3, ADCT Shigella
strains, and puriﬁed GST and A559, were analysed by SDS–PAGE
and anti IpaA-immunoblotting. A559 was detected by staining with
Coomassie blue. (C) Binding of the IpaA derivatives to vinculin was
tested in overlay assays.3. Results
3.1. The C-terminus of IpaA is suﬃcient to reveal the latent
F-actin binding potential of vinculin
To identify the domain of IpaA that mediates its interactions
with vinculin overlay assays were performed. We generated
IpaA derivatives containing internal deletions between residues
69–139 (AD1) and 139–420 (AD2), carboxyl-terminal deletions
of residues 419–633 (AD3) and 559–633 (ADCT), as well as a
GST-fusion protein containing IpaA C-terminal residues
560–633 (A559) (Fig. 1A). These IpaA derivatives were ex-
pressed and migrated at their expected sizes in SDS–PAGE
(Fig. 1B). Full length IpaA, the internal IpaA deletions AD1
and AD2, as well as the C-terminal fusion A559, all bound
to full-length human vinculin (HV, Fig. 1C). However, the
AD3 and ADCT mutant IpaA proteins failed to bind to HV
(Fig. 1C).
To address the role of the IpaA vinculin-binding domain in
regulating vinculin–F-actin interactions, actin sedimentation
assays were performed with the A559 and HV proteins. As ex-
pected, when HV (1.8 lM) and F-actin (3 lM) were incubated
together the majority of the actin pool was recovered in its
polymerised form in the pellet fraction whereas HV was mostly
found in the soluble fraction (Fig. 2A). Addition of A559,
however, led to a signiﬁcant shift of HV into the pellet fraction
with polymerised actin (Fig. 2A). Quantiﬁcation by scanning
densitometry indicated that the percentage of the total pool
of HV associated with F-actin shifted from 13% in the absence
of A559 to 86% in the presence of 2 lM A559 (Fig. 2B).
Therefore, the last 74 C-terminal residues of IpaA are suﬃ-
cient to induce the association of vinculin with actin ﬁlaments.3.2. A559–HV induces vinculin-dependent partial barbed-end
capping of actin ﬁlaments
To analyse the eﬀects of the A559–vinculin interaction on
actin dynamics, the rate of barbed end growth of actin ﬁla-ments was measured by monitoring changes in pyrenyl-labeled
actin ﬂuorescence. Eﬀects of barbed end elongation were stud-
ied using spectrin-actin seeds, which are short actin ﬁlaments
capped at their pointed ends. When A559 was added at con-
centrations ranging from 0 to 875 nm to HV at a concentration
of 2 lM, partial inhibition of actin polymerisation was ob-
served, plateauing at 40% inhibition at saturating amounts of
A559 (>800 nM, Fig. 3A). A similar limited 40% inhibition
was observed at higher concentrations of HV (8 lM) in the
presence of 10 lMA559, demonstrating that the partial inhibi-
tion of barbed ends did not result from partial saturation of
barbed ends (not shown). When the reverse experiments were
performed in which increasing concentrations of HV were
added to 0.9 lM of A559, a partial inhibition of actin polymer-
isation was again observed, with 40% inhibition occurring at
concentrations of HV greater than 1.8 lM (Fig. 3B, inset).
In contrast, neither HV alone nor A559 alone aﬀected the ini-
Fig. 2. A559 induces vinculin co-sedimentation with F-actin. (A) Actin
(3 lM), was allowed to polymerise in F-buﬀer in the presence of 2 lM
vinculin (0), or 2 lM vinculin and increasing concentrations of A559.
Proteins were separated by ultracentrifugation. Pellets (P) and super-
natants (S) were analysed by SDS–PAGE and Coomassie blue dye
staining. The apparent migration of proteins is indicated by an arrow.
The concentration of A559 is indicated in lM above the lanes. (B) The
intensity of the band corresponding to HV in S or P fractions was
determined by scanning densitometry and expressed as the percentage
of the total (P + S).
Fig. 3. A559 mediates vinculin-dependent capping of actin ﬁlaments at bar
pyrenyl-labelled (10%) actin assembly was monitored in the presence of spectr
increasing concentrations of A559 (values are indicated in nM) and 1.8 lMH
concentrations of A559 (0–8 lM) in the presence of 0.9 lM HV (solid circles
(0–2 lM) added to 0.9 lMA559. (C) Plots of the initial elongation rates (V0)
(0–20 lM). (D) For polymerisation at pointed ends, kinetics of pyrenyl-labell
buﬀer alone (red), 2 lM HV (green), or 2 lM HV and 1 lM A559 (orange).
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15 lM indicating that inhibition was mediated by the A559–
HV complex (Fig. 3C). Inhibition mediated by A559–HV
was speciﬁc for barbed ends, since no detectable eﬀects on
pointed end growth could be observed when gelsolin-actin
seeds were used (Fig. 3D).
A559–HV did not aﬀect actin polymerisation in steady state
experiments in the absence or presence of gelsolin, indicating
that the A559–HV complex does not prevent actin polymerisa-
tion by sequestering actin monomers (Figs. 4A and B). Initial
rates of ﬁlaments elongation grown from spectrin-actin seeds
were plotted as a function of actin concentration [20]. As
shown in Fig. 4C, addition of A559–HV did not aﬀect the crit-
ical concentration at barbed ends, since the abscissa intercept
of the plots indicated a value indistinguishable from actin
alone, corresponding to the expected value of 0.1 lM. The rate
of association of monomer to barbed ends was, however, sig-
niﬁcantly aﬀected by saturating concentrations of A559
(0.9 lM) and HV (1.8 lM), with the association constant k+
shifting from 9.2 lM1 s1 for actin alone to 6.5 lM1 s1 in
the presence of A559–HV (Fig. 4C).
Collectively, these results demonstrate that A559 induces
vinculin-dependent leaky capping of actin ﬁlaments at their
barbed end, thus modulating the rate of association of mono-
mers at this end.bed ends. For polymerisation studies at barbed ends kinetics of 2 lM
in-actin seeds. (A) Kinetics of barbed ends elongation in the presence of
. (B) Plots of the initial elongation rates (Vo) as a function of increasing
) or 8 lM HV (empty squares); inset: increasing concentrations of HV
in the presence of increasing concentrations of HV alone or A559 alone
ed actin assembly was monitored in the presence of gelsolin seeds with
Fig. 4. Steady state actin polymerization indicates an interference of HV–A559 on actin monomer association with the ﬁlament’s barbed ends. Actin
(2 lM) (A), or actin in the presence of gelsolin (B) was allowed to polymerise for 16 h with HV (0–2 lM) (solid diamonds), A559 (0–1 lM) (empty
circles), or 2 lMHV and A559 (0–1 lM) (solid squares). (C), The initial rate of actin polymerisation was plotted as a function of actin concentration
(Cc plot) in the presence of 0.9 lM A559 and 1.8 lM vinculin.
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Remodeling of the cellular actin ﬁlament network is regu-
lated by actin binding proteins that either nucleate actin poly-
merisation or destabilise F-actin to promote rapid spatial
control of ﬁlament assembly and disassembly, respectively
[20,21]. Here we show that a C-terminal domain of Shigella’s
IpaA protein (A559) binds to vinculin and induces its associa-
tion with F-actin in stoichiometric amounts in the micromolar
range. This suggests that at these concentrations, the A559–
vinculin complex essentially binds to the sides of actin ﬁla-
ments. Steady state polymerisation experiments, however, indi-
cate that binding of the A559–vinculin complex to the sides of
actin ﬁlaments does not impact the dynamics of actin polymer-
ization. Instead, we show that the eﬀects of A559–HV complex
on actin dynamics is linked to partial capping of the barbed
ends of actin ﬁlaments. ‘‘Leaky cappers’’ provide a means to
control actin dynamics in various manners. For example,
mDia1 formin acts as a leaky capper that slows down associa-
tion and dissociation of actin at barbed ends [22]. Yet, in the
presence of proﬁlin, mDia1 increases the rate of association
of proﬁlin–actin at barbed ends and induces processive poly-
merisation [23]. Along these lines, IpaA-mediated vinculin cap-
ping of actin ﬁlaments may exert distinct eﬀects during the
process of bacterial entry. For example, IpaA-mediated vincu-
lin-dependent capping of actin ﬁlaments may inhibit thegrowth of protrusions at sites of bacteria–cell contact, to avoid
repulsion of the bacterium during the initial phase of bacterial
invasion. At later stages of infection, the capping activity of
the IpaA–vinculin complex could combine with the eﬀect of
sequestering or depolymerising proteins to account for actin
depolymerisation during the completion of the entry process
[4]. As opposed to full length IpaA, however, A559 did not in-
duce actin depolymerisation in vitro in the presence of vincu-
lin, or after cell microinjection (data not shown) or
transfection [24]. This suggests that depolymerisation involved
IpaA domains other than the last 74 carboxyterminal residues.
Unfortunately, the fact that full length IpaA was soluble only
in the presence of detergents that interfered with the measure
of pyrenyl–actin assembly, did not allow us to test this hypoth-
esis (our unpublished data). Interestingly, the crystal structure
of the Vh1 domain of vinculin in complex with IpaA’s binding
region, has established that vinculin undergoes structural
changes that are similar to those observed upon activation
with a talin-VBS [25]. Therefore, the leaky barbed end capping
activity of vinculin may also reﬂect a function of vinculin that
is manifest when it is bound to its native ligands in focal adhe-
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